Interferon and kidney cancer: a promise unfulfilled?
Naitoh
J
J
Department of Urology, University of California, Los Angeles 90095, USA.
Belldegrun
A S
AS
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D007371:Interferon-gamma / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D011994:Recombinant Proteins; D007371:Interferon-gamma